Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (11)

Advertisement

Research Article Free access | 10.1172/JCI107097

Correction for Mechanical Dead Space in the Calculation of Physiological Dead Space

Gloria J. Singleton, C. Robert Olsen, and Richard L. Smith

Chest Section of the Medical Service, Veterans Administration (Wadsworth) Hospital and University of California at Los Angeles School of Medicine, Los Angeles, California 90073

Find articles by Singleton, G. in: JCI | PubMed | Google Scholar

Chest Section of the Medical Service, Veterans Administration (Wadsworth) Hospital and University of California at Los Angeles School of Medicine, Los Angeles, California 90073

Find articles by Olsen, C. in: JCI | PubMed | Google Scholar

Chest Section of the Medical Service, Veterans Administration (Wadsworth) Hospital and University of California at Los Angeles School of Medicine, Los Angeles, California 90073

Find articles by Smith, R. in: JCI | PubMed | Google Scholar

Published October 1, 1972 - More info

Published in Volume 51, Issue 10 on October 1, 1972
J Clin Invest. 1972;51(10):2768–2772. https://doi.org/10.1172/JCI107097.
© 1972 The American Society for Clinical Investigation
Published October 1, 1972 - Version history
View PDF
Abstract

When physiological dead space (Vdp) is calculated for a patient who has alveolar dead space, e.g., after pulmonary vascular occlusion, less than the full volume of attached mechanical dead space (Vdm) appears in the measured dead space (Vdn). Under these conditions the traditional subtraction of Vdm from Vdn leads to underestimation of Vdp and can give a falsely small ratio of Vdp to tidal volume (Vt) when, in fact, an abnormally large Vdp/Vt exists. To make the proper correction for Vdm, two equations have been derived and validated with seven subjects having Vdp/Vt from 0.29 to 0.87, using Vdm's from 120 to 322 ml. With only a small modification, these equations are suitable for routine clinical use and give Vdp/Vt within 0.02 of that by the validated equations (32 of 33 comparisons). The fraction of Vdm subtracted from Vdn is the square of the ratio of effective alveolar to total alveolar ventilation and is never > 1. This fraction is (PaCO2/PaCO2)2, where PaCO2 and PaCO2 are the mean partial pressures of expired alveolar and of arterial CO2; in the other equation this fraction is [PeCO2/PaCO2 (Vt — Vdan — Vdm)]2 where PeCO2 is mixed expired Pco2 and Vdan is anatomical dead space. The second equation requires an estimated Vdan and is applicable when PaCO2 is not measured or does not plateau (as in exercise).

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2768
page 2768
icon of scanned page 2769
page 2769
icon of scanned page 2770
page 2770
icon of scanned page 2771
page 2771
icon of scanned page 2772
page 2772
Version history
  • Version 1 (October 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (11)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts